Kristina Anne Dahl, M.D., and Ginger Barfield Susan Thomas Gino Olivieri and Cheryl Gates v. Hem Pharmaceutical Corp., a Pennsylvania Corporation and Hem Research, Inc., a Pennsylvania Corporation, Kristina Anne Dahl, M.D. v. Hem Pharmaceutical Corp., a Pennsylvania Corporation and Hem Research, Inc., a Pennsylvania Corporation

76 F.3d 385 NOTICE: Ninth Circuit Rule 36-3 provides that dispositions other than opinions or orders designated for publication are not precedential and should not be cited except when relevant under the doctrines of law of the case, res judicata, or collateral estoppel. Kristina Anne DAHL, M.D., Plaintiff, and Ginger Barfield; Susan Thomas; Gino Olivieri; and Cheryl Gates, Plaintiffs-Appellants, v. HEM PHARMACEUTICAL CORP., a Pennsylvania corporation; and HEM Research, Inc., a Pennsylvania corporation, Defendants-Appellees. Kristina Anne DAHL, M.D., Plaintiff-Appellant, v. HEM PHARMACEUTICAL CORP., a Pennsylvania corporation; and HEM Research, Inc., a Pennsylvania corporation, Defendants-Appellees. Nos. 94-16371, 94-16456. United States Court of Appeals, Ninth Circuit. Argued and Submitted Jan. 10, 1996. Decided Feb. 2, 1996. Before: LAY, * CHOY, and PREGERSON, Circuit Judges. 1 MEMORANDUM ** I. Factual and Procedural Background 2 Appellants suffer from the debilitating disease Chronic Fatigue Syndrome ("CFS"). Beginning in 1990 appellee HEM Pharmaceuticals Corporation ("HEM") conducted a double-blind clinical trial of Ampligen, an experimental drug treatment for CFS. HEM…